towards precision medicine in - medinews.it · [email protected] napoli francesco...
TRANSCRIPT
MEDITERRANEAN SCHOOL OF ONCOLOGYwww.mso.cinbo.org
DIRECTORClara Natoli
SCIENTIFIC SECRETARIATConsiglia CarellaMichele De Tursi
Antonino GrassadoniaNicola Tinari
SCIENTIFIC ADVISORY BOARDVincenzo AdamoBarbara BarboniRoberto BiancoGiovanni Brandi
Marco CariniLeonardo Della Salda
Corrado FicorellaFrancesco Grignani
Lorenzo Lo MuzioPatrizia QuerzoliAntonio Russo
Marina ScarpelliSilverio Tomao
Giuseppe Tonini
ORGANIZING SECRETARIATGiovanna Di Credico
OFFICESConsorzio Interuniversitario Nazionale
per la Bio-Oncologia (CINBO)c/o Sezione di Oncologia Medica
Università G. D’Annunzio - Via dei Vestini, 3166100 Chieti - Italy
Phone: +39 0871 3556732Fax +39 0871 3556707
PROVIDER ECM ID. 50Strategie S.r.L. - Via Piave 110/7 - Pescara
Phone: 085 74143 - Fax: 085 [email protected]
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
presents
TOWARDS PRECISION MEDICINE IN CANCER TREATMENT
May 26, 2017Auditorium c/o RettoratoUniversità degli Studi “G. D’Annunzio”Via dei Vestini, 31Chieti
DirectorsPaolo Marchetti & Clara Natolim
so.c
inb
o.o
rg
CINBOConsorzio Interuniversitario Nazionaleper la Bio-Oncologia
Evento n. ECM 50-190187 per Medici Chirurghi specialisti in: ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; DERMATOLOGIA EVENEREOLOGIA; EMATOLOGIA; ENDOCRINOLOGIA; GENETICAMEDICA; MALATTIE DELL’APPARATO RESPIRATORIO; MEDICINA
INTERNA; NEFROLOGIA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIAGENERALE; CHIRURGIA PLASTICA E RICOSTRUTTIVA; CHIRURGIA
TORACICA; GINECOLOGIA E OSTETRICIA; UROLOGIA; ANATOMIAPATOLOGICA; FARMACOLOGIA E TOSSICOLOGIA CLINICA;
MEDICINA NUCLEARE; PATOLOGIA CLINICA (LABORATORIO DIANALISI CHIMICOCLINICHE E MICROBIOLOGIA);
RADIODIAGNOSTICA; IGIENE, EPIDEMIOLOGIA E SANITÀPUBBLICA; CURE PALLIATIVE; EPIDEMIOLOGIA;
per Farmacisti (Farmacia Ospedaliera); per (Farmacia Ospedaliera); per Biologi
Crediti ECM: 6
si ringrazia per il contributo incondizionato:
La partecipazione è gratuita. Le iscrizioni si accettano esclusivamente on line sul sito del Provider www.strategieonweb.it - pagina ECM 2017
Con il patrocino di:
9.00 Registration & Wellcome coffee9.30 Opening Paolo Marchetti & Clara Natoli
Chair: Amedeo Pancotti and Nicola Tinari 09.50 The near future: P4 Medicine Saverio Alberti 10.10 Precision medicine-based clinical trials Clara Natoli 10.20 The impact of next-generation sequencing on precision medicine Antonio Marchetti 10.40 Discussion leaders Francesco Grignani & Paolo Marchetti
Coffee break
Chair: Teresa Martino and Lucio Laudadio11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment Mario Scartozzi 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime? Daniele Zanoni12.20 Discussion leaders Corrado Ficorella & Giovanni Brandi 12.40 Lecture Cancer immunotherapy and precision medicine Marianna Nuti
Light Lunch
Chair: Katia Cannita and Luciana Irtelli14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance Rita Chiari 14.50 MET receptor inhibition in solid tumors Roberto Bianco 15.10 Discussion leaders Riccardo Giampieri & Mario Roselli
Chair: Michele De Tursi and Luca Cindolo15.30 Targeting castration-resistant prostate cancer Arcangelo Sebastianelli15.50 BRAF and MEK inhibitors Antonio Grimaldi16.10 Discussion leaders Silverio Tomao & Vincenzo Adamo
Coffee break
Chair: Antonino Grassadonia and Consiglia Carella16.45 DNA Repair pathways as targets for cancer therapy Domenica Lorusso17:05 Biological and clinical impact of cancer stem cells in ovarian cancer Federica Tomao17.25 RANK as a therapeutic target in cancer Francesco Pantano
17.45 Discussion leaders Giuseppe Tonini & Matteo Landriscina18:05 Conclusions Paolo Marchetti & Clara Natoli
18.15 ECM18.15 ECM
Program Faculty Vincenzo [email protected]
Saverio [email protected]
Roberto [email protected]
Giovanni [email protected]
Katia [email protected]’Aquila
Consiglia [email protected] [email protected] Carella
Chieti
Rita [email protected]
Luca [email protected]
Michele De [email protected]
Corrado Ficorellacorrado.fi [email protected]’Aquila
Riccardo Giampieri [email protected]
Antonino [email protected]
Antonio [email protected]
Francesco [email protected] [email protected] Grignani
Perugia
Matteo [email protected]
Lucio [email protected]
Domenica [email protected]
Luciana [email protected]
Antonio [email protected]
Paolo [email protected]
Maria Teresa [email protected]
Clara [email protected]
Marianna [email protected]
Amedeo Pancotti [email protected]
Francesco [email protected]
Mario [email protected]
Mario [email protected] Cagliari
Arcangelo [email protected] [email protected] Sebastianelli
Firenze
Nicola [email protected]
Federica [email protected]
Silverio [email protected]
Giuseppe [email protected]
Daniele [email protected]
9.00 Registration & Wellcome coffee9.30 Opening
09.50 The near future: P4 Medicine 10.10 Precision medicine-based clinical trials 10.20 The impact of next-generation sequencing on precision medicine 10.40 Discussion leaders
11.00
11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime? 12.20 Discussion leaders 12.40 Lecture
13.30
14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance 14.50 MET receptor inhibition in solid tumors 15.10 Discussion leaders
16.30
15.30 Targeting castration-resistant prostate cancer 15.50 BRAF and MEK inhibitors 16.10 Discussion leaders
16.45 DNA Repair pathways as targets for cancer therapy 17:05 Biological and clinical impact of cancer stem cells in ovarian cancer 17.25 RANK as a therapeutic target in cancer
17.45 Discussion leaders 18:05 Conclusions
18.15 ECM18.15 ECM